BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Business

  SoCal’s Inogen Taps a New CEO

  December 6, 2016

   · 

  12 min read
• Drug Development

  Theravance Biopharma Receives FDA Fast Track Designation For Velusetrag (TD-5108) For Idiopathic And Diabetic Gastroparesis

  December 6, 2016

   · 

  10 min read
• Drug Development

  Mast Therapeutics Announces Initiation Of Patient Enrollment In Additional Phase 2 Study Of AIR001 For The Treatment Of Heart Failure With Preserved Ejection Fraction

  December 6, 2016

   · 

  8 min read
• Drug Development

  Senhwa Biosciences CX-4945 Phase I Clinical Trial Results Accepted For Presentation At The 2017 ASCO Gastrointestinal Cancers Symposium

  December 6, 2016

   · 

  2 min read
• Drug Development

  Cellectar Biosciences Presents Poster At The 58th Annual Meeting Of The American Society of Hematology

  December 6, 2016

   · 

  8 min read
• Drug Development

  Resverlogix Announces Second Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study Of Apabetalone (RVX-208)

  December 6, 2016

   · 

  3 min read
• Drug Development

  Cornerstone Pharmaceuticals, Inc. Presents Phase I Data On CPI-613 In Acute Myeloid Leukemia (AML) And T-Cell Non-Hodgkin’s Lymphoma (T-Cell NHL) At American Society of Hematology 2016

  December 6, 2016

   · 

  7 min read
• FDA

  Voluntis Wins FDA Clearance and CE Mark for Diabetes Management App, Insulia

  December 6, 2016

   · 

  4 min read
• Pharm Country

  Corbus To Ring The Nasdaq Stock Market Closing Bell

  December 6, 2016

   · 

  2 min read
• Drug Development

  Oncolytics Biotech Inc. Collaborators Present Initial Results From REO 019 Study In Multiple Myeloma Combining REOLYSIN, Bortezomib And Dexamethasone At The American Society of Hematology Annual Meeting

  December 6, 2016

   · 

  5 min read